Thu, Nov 12, 2026 - Page 24
13819 indexed SquawkNews stories from this UTC day. Showing 2761-2880.
L
AVAX ONE TECHNOLOGY LTD Q3 NET INCOME USD 49.892 MILLION
AVAX ONE TECHNOLOGY LTD Q3 NET INCOME USD 49.892 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
SOUNDTHINKING Q3 ADJUSTED EBITDA USD 2.207 MILLION
SOUNDTHINKING Q3 ADJUSTED EBITDA USD 2.207 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
INNOVATE Corp. Announces Third Quarter 2026 Results
INNOVATE Corp. Announces Third Quarter 2026 Results - Infrastructure: INNOVATE completes sale of DBM
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
TransAct Technologies Reports Preliminary Third Quarter 2026 Financial Results
Third Quarter 2026 Net Sales up 10% Year-over-Year FST Revenue up 33% Year-over-Year; FST Software R
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
VIRGIN GALACTIC Q3 NET INCOME USD -58.756 MILLION
VIRGIN GALACTIC Q3 NET INCOME USD -58.756 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
ACCELEVATION HOLDINGS CORP. REPORTS STRONG THIRD QUARTER 2026 WITH REVENUE GROWTH OF 66%, BOOKINGS GROWTH OF OVER 350%, AND ROBUST CASH GENE
ACCELEVATION HOLDINGS CORP. REPORTS STRONG THIRD QUARTER 2026 WITH REVENUE GROWTH OF 66%, BOOKINGS G
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
UNITED STATES ANTIMONY Q3 GROSS MARGIN 46%
UNITED STATES ANTIMONY Q3 GROSS MARGIN 46%
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SYSTEM1 INC. Q3 ADJUSTED EBITDA USD -700 THOUSAND
SYSTEM1 INC. Q3 ADJUSTED EBITDA USD -700 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
AVAX ONE TECHNOLOGY LTD Q3 EPS USD 6.11
AVAX ONE TECHNOLOGY LTD Q3 EPS USD 6.11
EARNINGS | Nov 12, 2026, 09:06 PM UTC
M
Cisco Q1 Revenue Reaches USD 18,500 Million
Cisco reported Q1 revenue of USD 18,500 million versus an IBES estimate of USD 18,135 million.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
US Global Investors 1Q EPS 1c >GROW
US Global Investors 1Q EPS 1c >GROW
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLUENT Q3 OPERATING INCOME USD -3.119 MILLION
FLUENT Q3 OPERATING INCOME USD -3.119 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
AVAX ONE REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS
AVAX ONE REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
CANDEL THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -22.981 MILLION VS. IBES ESTIMATE USD -25.4 MILLION
CANDEL THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -22.981 MILLION VS. IBES ESTIMATE USD -25.4 MILLIO
FX | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS Q3 NET INCOME USD 14.4 MILLION
FLOWERS FOODS Q3 NET INCOME USD 14.4 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Relmada Therapeutics Q3 EPS USD -0.12
Nov 12 (Reuters) - Relmada Therapeutics Q3 net income USD -13.9 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-VirTra Q3 EPS USD 0.19
Nov 12 (Reuters) - VirTra Q3 revenue USD 7.6 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SYSTEM1 INC. Q3 ADJUSTED GROSS PROFIT USD 21.9 MILLION
SYSTEM1 INC. Q3 ADJUSTED GROSS PROFIT USD 21.9 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
HIREQUEST Q3 ADJUSTED EBITDA USD 4.5 MILLION
HIREQUEST Q3 ADJUSTED EBITDA USD 4.5 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Pliant Therapeutics 3Q Loss/Shr 39c >PLRX
Pliant Therapeutics 3Q Loss/Shr 39c >PLRX
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
AKARI THERAPEUTICS Q3 NET INCOME USD -4.8 MILLION
AKARI THERAPEUTICS Q3 NET INCOME USD -4.8 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-LifeMD Inc Q3 Gross Margin 82%
Nov 12 (Reuters) - LifeMD Inc Q3 revenue USD 44.6 million vs. IBES estimate USD 48.9 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Evommune Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Expanded pipeline with in-licensing of EVO570, a potential best-in-class oral VAV1 molecular glue
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Rekor Systems Reports Third Quarter 2026 Financial Results
Rekor Systems Reports Third Quarter 2026 Financial Results COLUMBIA, Md., Nov. 12, 2026 (GLOBE NEWSW
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-OpenWorld, Inc. Q3 Gross Margin 80%
Nov 12 (Reuters) - OpenWorld, Inc. Q3 revenue USD 7.4 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
MERLIN INC Q3 NET INCOME USD 73.837 MILLION
MERLIN INC Q3 NET INCOME USD 73.837 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Buda Juice, Inc. (BUDA) Q3 Revenue Rose 64% to $5.2M
Third-quarter 2026 revenue rose 64% year over year to $5.2M, versus $3.2M. Net income was $0.9M, essentially flat year over year, while adjusted EBITDA rose 35% to $1.3M from $1.0M.Material DetailsContext by AI AnalystTh
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS Q3 ADJUSTED NET INCOME USD 21.4 MILLION
FLOWERS FOODS Q3 ADJUSTED NET INCOME USD 21.4 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
MERLIN, INC. REPORTS THIRD QUARTER 2026 RESULTS
MERLIN, INC. REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SELLAS LIFE SCIENCES Q3 NET INCOME USD -10.091 MILLION
SELLAS LIFE SCIENCES Q3 NET INCOME USD -10.091 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Pliant Therapeutics Q3 Net Income USD -24.377 Million
Nov 12 (Reuters) - Pliant Therapeutics Q3 operating income USD -25.742 million.
FX | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES Q3 GROSS MARGIN 46.4%
TRANSACT TECHNOLOGIES Q3 GROSS MARGIN 46.4%
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million
Nov 12 (Reuters) - 4D Molecular Therapeutics Q3 basic EPS USD -1.08.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BIOSTEM TECHNOLOGIES, INC. Q3 EPS USD -0.64
BIOSTEM TECHNOLOGIES, INC. Q3 EPS USD -0.64
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES OUTLOOK FY REVENUE USD 55-56 MILLION
TRANSACT TECHNOLOGIES OUTLOOK FY REVENUE USD 55-56 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Crown Crafts Q2 EPS USD 0.12
Nov 12 (Reuters) - Crown Crafts Q2 revenue USD 19.028 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SHIMMICK CORP Q3 REVENUE USD 136 MILLION
SHIMMICK CORP Q3 REVENUE USD 136 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights Lis
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Candel Therapeutics Q3 Net Income USD -21.873 Million
Nov 12 (Reuters) - Candel Therapeutics Q3 operating expenses USD 22.981 million.
FX | Nov 12, 2026, 09:06 PM UTC
M
Cerebras Systems Expects Revenue to Triple in 2027
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-SoundThinking Q3 Net Income USD -8.472 Million
Nov 12 (Reuters) - SoundThinking Q3 adjusted EBITDA USD 2.207 million.
FX | Nov 12, 2026, 09:06 PM UTC
L
Spruce Power Reports Third Quarter 2026 Results
Net income attributable to stockholders of $6.0 million Operating EBITDA of $27.0 million SG&A down
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027
U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Qua
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS Q3 ADJUSTED EBITDA USD 78.9 MILLION
FLOWERS FOODS Q3 ADJUSTED EBITDA USD 78.9 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Intellicheck Q3 Revenue USD 5.739 Million
Nov 12 (Reuters) - Intellicheck Q3 operating expenses USD 4.85 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Fluent Q3 Net Income USD -3.125 Million
Nov 12 (Reuters) - Fluent Q3 revenue USD 53.642 million vs. IBES estimate USD 50.1 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Solesence Inc Q3 Gross Profit USD 7.928 Million
Nov 12 (Reuters) - Solesence Inc Q3 pretax profit USD 3.889 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES Q3 EPS USD -0.04
TRANSACT TECHNOLOGIES Q3 EPS USD -0.04
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Arcadia Biosciences Q3 Net Income USD 1.755 Million
Nov 12 (Reuters) - Arcadia Biosciences Q3 operating expenses USD 2.458 million.
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-System1 Inc. Q3 Revenue USD 26 Million
Nov 12 (Reuters) - System1 Inc. Q3 gross profit USD 20.7 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SYSTEM1 INC. Q3 NET INCOME USD -61.5 MILLION
SYSTEM1 INC. Q3 NET INCOME USD -61.5 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Spruce Power Q3 Revenue USD 29.693 Million
Nov 12 (Reuters) - Spruce Power Q3 income from operations USD 8.455 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-ImmuCell Corporation Q3 EPS USD 0.1
Nov 12 (Reuters) - ImmuCell Corporation Q3 pretax profit USD 936 thousand.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SHIMMICK CORP OUTLOOK FY ADJUSTED EBITDA USD 15-30 MILLION
SHIMMICK CORP OUTLOOK FY ADJUSTED EBITDA USD 15-30 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Codexis Q3 Basic EPS USD -0.08
Nov 12 (Reuters) - Codexis Q3 net income USD -8.128 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-TransAct Technologies Q3 EPS USD -0.04
Nov 12 (Reuters) - TransAct Technologies Q3 adjusted EBITDA USD 289 thousand.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Accelevation Holdings Corp. Reports Strong Third Quarter 2026 with Revenue Growth of 66%, Bookings Growth of over 350%, and Robust Cash Gene
Accelevation Holdings Corp. Reports Strong Third Quarter 2026 with Revenue Growth of 66%, Bookings G
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-SELLAS Life Sciences Q3 Net Income USD -10.091 Million
Nov 12 (Reuters) - SELLAS Life Sciences Q3 operating expenses USD 11.309 million.
FX | Nov 12, 2026, 09:06 PM UTC
L
Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentia
Initiated GLP toxicology studies of lead TROP2-targeted ADC AKTX-101 to enable planned Phase 1 trial
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
PEDEVCO CORP OUTLOOK FY ADJUSTED EBITDA USD 60-70 MILLION
PEDEVCO CORP OUTLOOK FY ADJUSTED EBITDA USD 60-70 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
H
Flowers Foods, Inc. (FLO) Adjusts 2026 Guidance After Challenging Quarter
Flowers Foods reported third-quarter 2026 results and adjusted its 2026 guidance, citing performance and current conditions. Management expects the environment to remain challenging in the near term; the release text pro
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
NorthStar Earth & Space Reports Third Quarter 2026 Results
NorthStar Earth & Space Inc. (“Legacy NorthStar”), a space domain awareness (SDA) company and wholly-owned subsidiary of NorthStar Earth & Space Enterprises, Inc. (“NorthStar” or the “Company”), whose common shares and p
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Virgin Galactic Q3 Revenue USD 427 Thousand Vs. IBES Estimate USD 400 Thousand
Nov 12 (Reuters) - Virgin Galactic Q3 net income USD -58.756 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
ARMATA PHARMACEUTICALS ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER 2026 AND PROVIDES CORPORATE UPDATE
ARMATA PHARMACEUTICALS ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER 2026 AND PROVIDES CORPORATE
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BIOSTEM TECHNOLOGIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS; GROWS HOSPITAL REVENUE FOR SECOND CONSECUTIVE QUARTER AS CUSTOMERS EXPAND
BIOSTEM TECHNOLOGIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS; GROWS HOSPITAL REVENUE FOR SECOND
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES Q3 SALES USD 14.4 MILLION
TRANSACT TECHNOLOGIES Q3 SALES USD 14.4 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Flowers Foods Q3 Adjusted EPS USD 0.1 Vs. IBES Estimate USD 0.15
Nov 12 (Reuters) - Flowers Foods Q3 sales USD 1,169 million vs. IBES estimate USD 1,180 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Sensus Healthcare Q3 Net Income USD -1.493 Million
Nov 12 (Reuters) - Sensus Healthcare Q3 basic EPS USD -0.09.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Digimarc Q3 Revenue USD 6.446 Million
Nov 12 (Reuters) - Digimarc Q3 operating income USD -8.021 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SENSUS HEALTHCARE Q3 REVENUE USD 5.995 MILLION VS. IBES ESTIMATE USD 6.61 MILLION
SENSUS HEALTHCARE Q3 REVENUE USD 5.995 MILLION VS. IBES ESTIMATE USD 6.61 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
INTRUSION Q3 GROSS MARGIN 55%
INTRUSION Q3 GROSS MARGIN 55%
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update
LOS ANGELES, Nov. 12, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-HireQuest Q3 Revenue USD 8.8 Million
Nov 12 (Reuters) - HireQuest Q3 adjusted EBITDA USD 4.5 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BUDA JUICE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
BUDA JUICE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-NeuroPace, Inc. Q3 EPS USD -0.1
Nov 12 (Reuters) - NeuroPace, Inc. Q3 revenue USD 23.104 million vs. IBES estimate USD 27.2 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Lineage Cell Therapeutics Q3 Net Income USD 4.23 Million
Nov 12 (Reuters) - Lineage Cell Therapeutics Q3 income from operations USD -7.314 million.
FX | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES Q3 OPERATING INCOME USD -415 THOUSAND
TRANSACT TECHNOLOGIES Q3 OPERATING INCOME USD -415 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
NEUROPACE, INC. Q3 REVENUE USD 23.104 MILLION VS. IBES ESTIMATE USD 27.2 MILLION
NEUROPACE, INC. Q3 REVENUE USD 23.104 MILLION VS.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
INTRUSION Q3 REVENUE USD 2.68 MILLION
INTRUSION Q3 REVENUE USD 2.68 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
HIREQUEST REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2026
HIREQUEST REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2026
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 EPS USD 0.12
CROWN CRAFTS Q2 EPS USD 0.12
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2026 RESULTS
FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Tenon Medical Q3 Net Income USD -6.639 Million
Nov 12 (Reuters) - Tenon Medical Q3 revenue USD 1.432 million.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
CODEXIS Q3 PRODUCT REVENUE USD 15.74 MILLION
CODEXIS Q3 PRODUCT REVENUE USD 15.74 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Wealthfront to Announce Fiscal Third Quarter 2027 Financial Results on December 3, 2026
Wealthfront to Announce Fiscal Third Quarter 2027 Financial Results on December 3, 2026 PALO ALTO, C
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2026 Results
GLYFADA, Greece, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus” or the “Company
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
VIRGIN GALACTIC Q3 REVENUE USD 427 THOUSAND VS. IBES ESTIMATE USD 400 THOUSAND
VIRGIN GALACTIC Q3 REVENUE USD 427 THOUSAND VS. IBES ESTIMATE USD 400 THOUSAND
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
BRIEF-Vuzix Q3 Net Income USD -8.386 Million
Nov 12 (Reuters) - Vuzix Q3 operating income USD -8.477 million.
FX | Nov 12, 2026, 09:06 PM UTC
L
Dillard's 3Q EPS $8.38 >DDS
Dillard's 3Q EPS $8.38 >DDS
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES Q3 ADJUSTED EBITDA USD 289 THOUSAND
TRANSACT TECHNOLOGIES Q3 ADJUSTED EBITDA USD 289 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
Once Upon a Farm Reports Third Quarter 2026 Financial Results
Third quarter net sales increased 35% year-over-year to $89 million Updating 2026 net sales and adju
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update Azora T
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
HireQuest Reports Financial Results for Third Quarter 2026
GOOSE CREEK, S.C., Nov. 12, 2026 /PRNewswire/ -- HireQuest (Nasdaq: HQI), a national franchisor of o
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
INTELLICHECK Q3 INCOME FROM OPERATIONS USD 367 THOUSAND
INTELLICHECK Q3 INCOME FROM OPERATIONS USD 367 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and Annual Run Rate Now Exceeds $145 Million
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Enhanced Group, Inc. (ENHA) Reports $3.3M Q3 Revenue, $13.5M Net Loss
Enhanced Group reported Q3 2026 revenue of $3.3M versus $17.7M in Q2 and none a year earlier; net loss was $13.5M versus $61.9M in Q2 and $5.9M a year earlier. The company also expects combined 2027 revenue of approximat
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
AZORA THERAPEUTICS REPORTS 2026 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
AZORA THERAPEUTICS REPORTS 2026 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
ARCADIA BIOSCIENCES (RKDA) ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
ARCADIA BIOSCIENCES (RKDA) ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES Q3 NET INCOME USD -440 THOUSAND
TRANSACT TECHNOLOGIES Q3 NET INCOME USD -440 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
OBSIDIAN THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES
OBSIDIAN THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
DIGIMARC REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
DIGIMARC REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
M
Cisco Systems Reports 1Q Revenue of $18.5 Billion
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SCRIBE THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
SCRIBE THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Sensus Healthcare (SRTS) Q3 Revenue Falls 13% to $6.0M
Q3 revenue fell 13.0% year over year to $6.0M; gross margin rose to 55% from 39.1%. Net loss widened to $1.5M, or $0.09 per share, from $0.9M, or $0.06 per share.Material DetailsContext by AI AnalystThis is a quarterly r
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
ENHANCED GROUP INC. REPORTS THIRD QUARTER 2026 RESULTS
ENHANCED GROUP INC. REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Bolt Biotherapeutics 3Q Loss/Shr $2.25 >BOLT
Bolt Biotherapeutics 3Q Loss/Shr $2.25 >BOLT
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
MERLIN INC Q3 REVENUE USD 3.461 MILLION
MERLIN INC Q3 REVENUE USD 3.461 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Spruce Power Holding Corporation (SPRU) Reports $6.0M Q3 Net Income
Spruce Power Holding Corporation reported Q3 2026 revenue of $29.7M versus $30.7M in Q3 2025, and net income of $6.0M versus a $0.9M net loss. Diluted EPS was $0.28 versus a $0.05 loss per share.Material DetailsContext b
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results
FREDERICK, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
PEDEVCO CORP Q3 ADJUSTED EBITDA USD 14.68 MILLION
PEDEVCO CORP Q3 ADJUSTED EBITDA USD 14.68 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
IMMUCELL CORPORATION Q3 BASIC EPS USD 0.1
IMMUCELL CORPORATION Q3 BASIC EPS USD 0.1
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2026 RESULTS
THOMASVILLE, Ga., Nov. 12, 2026 // -- Flowers Foods, Inc. (NYSE:FLO) today reported financial results for the company's 12-week third quarter ended October 10, 2026.Third Quarter Summary:Compared to the prior year third
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
HIREQUEST Q3 REVENUE USD 8.8 MILLION
HIREQUEST Q3 REVENUE USD 8.8 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentia
Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress To
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
INTELLICHECK REPORTS THIRD QUARTER 2026 RESULTS
INTELLICHECK REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2026 RESULTS
THOMASVILLE, Ga., Nov. 12, 2026 /PRNewswire/ -- Flowers Foods, Inc.
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SOLESENCE INC Q3 PRETAX PROFIT USD 3.889 MILLION
SOLESENCE INC Q3 PRETAX PROFIT USD 3.889 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
FLOWERS FOODS Q3 SALES USD 1,169 MILLION VS. IBES ESTIMATE USD 1,180 MILLION
FLOWERS FOODS Q3 SALES USD 1,169 MILLION VS. IBES ESTIMATE USD 1,180 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
H
Grown Rogue International Inc. (GRIN) Maintains 2026 And 2027 Guidance
Grown Rogue reported unaudited results for the three and nine months ended September 30, 2026, and maintained its previously announced 2026 and 2027 revenue and Adjusted EBITDA guidance, which excludes New York.Material
EARNINGS | Nov 12, 2026, 09:05 PM UTC